ASCO issues guideline for febrile neutropenia in adults

January 15, 2013
ASCO issues guideline for febrile neutropenia in adults
The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations have been published online Jan. 14 in the Journal of Clinical Oncology.

(HealthDay)—The American Society of Clinical Oncology has issued updated recommendations for both the prevention and management of febrile episodes in neutropenic oncology outpatients; the recommendations have been published online Jan. 14 in the Journal of Clinical Oncology.

Christopher R. Flowers, M.D., from Emory University in Atlanta, and colleagues conducted a literature review and identified 43 studies assessing development of fever and/or infections in afebrile neutropenic outpatients with cancer, or treatment of fever and in outpatients with cancer. Data extracted from the studies were used to inform guidelines.

The recommends that antibacterial and antifungal prophylaxis should only be used for patients expected to have <100 neutrophils/µL for more than seven days, unless other factors increase risks for complications or mortality to similar levels. Febrile neutropenic episodes should be managed with inpatient treatment, although carefully selected patients may be managed as outpatients, including those with a Multinational Association for Supportive Care in Cancer score of 21 or higher or those in Talcott's rules group 4. Initial doses of empirical antibacterial therapy should be received by febrile neutropenic patients within an hour of triage, and they should either be monitored for at least four hours to determine suitability for outpatient management or admitted to the hospital. Empiric therapy should include an oral fluoroquinolone plus amoxicillin/clavulanate (or plus clindamycin if penicillin allergic), unless fluoroquinolone prophylaxis was used before fever developed.

"One major limitation of the evidence available to inform this guideline is the absence of data from that either studied the net effect on or compared the efficacy and safety of alternative regimens for antibacterial prophylaxis specifically in afebrile neutropenic outpatients," the authors write.

Explore further: New guidelines issued for pediatric fever and neutropenia

More information: Abstract
Full Text

Related Stories

New guidelines issued for pediatric fever and neutropenia

September 19, 2012
(HealthDay)—New evidence-based guidelines have been compiled on the management of fever and and neutropenia (FN) in children with cancer and/or who are undergoing hematopoietic stem-cell transplantation; the guidelines ...

Full weight-Based chemo doses recommended for obese

April 6, 2012
(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses ...

ASCO issues recommendations to improve cancer survivor care

January 10, 2013
(HealthDay)—The American Society of Clinical Oncology (ASCO) has presented recommendations for promoting high-quality cancer survivorship care in a report published online Jan. 7 in the Journal of Clinical Oncology.

New findings highlight the challenges of managing blood clotting in cancer patients

October 1, 2012
New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.

New guidelines issued for biopsy use in melanoma patients

July 9, 2012
(HealthDay) -- Sentinel lymph node biopsy -- a minimally invasive surgical technique that lets doctors see whether cancer has spread -- should be performed on patients with melanoma tumors of intermediate thickness and may ...

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.